Preview

Meditsinskiy sovet = Medical Council

Advanced search

House dust mites: invisible signs of visible problems. Modern approaches to the treatment of dust mite allergies

https://doi.org/10.21518/2079-701X-2013-7-59-65

Abstract

Allergic rhinitis (AR) is a chronic allergic disease caused by IgE-dependent allergic inflammation. It occurs when allergens affect the nasal mucosa and is clinically manifested by rhinorrhea, nasal congestion, sneezing, and sometimes anosmia [1].

About the Authors

О. O.s. drobik
РМАПО
Russian Federation


А. A.yu. nasunova
ГКБ №52, Москва
Russian Federation


References

1. Bousquet J., Khaltaev N., Cruz A et al. ARIA Update // Allergy. 2008. V. 63 (suppl.)

2. Емельянов А.В., Федосеев Г.Б., Сергеева Г.Р. Распространенность бронхиальной астмы и аллергического ринита среди взрослого населения Санкт-Петербурга // Аллергология. 2002. №2. С. 17-21.

3. Howarth P. The development of guidelines for allergic rhinitis // Rev. Fr. Allergol. Immunol. Clin. 2001. Vol. 41. №1. Р 116-120.

4. Антонов Ю.В., Разваляева А.В. Сезонный аллергический ринит: диагностические и экономические аспекты // Рос. аллергол. журн. 2005. №3. С. 41-44.

5. Hellings PW., Fokkens WJ. Allergic rhinitis and its impact on otorhinolaryngology // Allergy 2006. Vol. 61. №6. P 656-664.

6. Bousquet J., Cauwenberg P Van, Khaltaev N. et al. Allergic rhinitis and its impact on asthma (ARIA): Pocket Guide; WHO initiative. Geneva, 2001.

7. Roberts G. et al. CEA 2012.

8. Celedon J.C., Milton D.K., Ramsey C.D. et al. Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood // J. Allergy Clin. Immunol. 2007. Jul. №120(1). Р 144-149.

9. Lodge C.J., Lowe A.J., Gurrin L.C. et al. House dust mite sensitization in toddlers predicts current wheeze at age 12 years // J. Allergy Clin. Immunol. 2011. Oct. №128(4). Р 782-788 e9.

10. Blomme K. et al. // Int. Arch. Allergy Immunol. 2013.

11. Hankin et al. Drug Benefit Trends. 2008.

12. Shaaban R et al. // Lancet. 2008. №372(9643). Р 1049-1057.

13. Profile of adult patients with severe respiratory allergies to house dust mite (HDMs) allergens: a survey in three European countries. Abstract EAACI. 2013.

14. Valovirta E., Lheritier-Barrand M., Tauleigne L., David M., Lemonnier L., Rolland C. Patient's perceptions and experience of house dust mite allergy in a European survey // Eur. Resp. Dis. 2012. №8(2). Р 123-128.

15. Muche-Borowski C., Kopp M., Reese I. et al. Allergy prevention // J. Dtsch. Dermatol. Ges. 2010. №8. Р 718-724.

16. Weiner J.M., Abramson M.J., Puy R.M. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials // BMJ. 1998. №317. Р 1624-1629.

17. Bahls C. In the clinic. Allergic rhinitis // Ann. Intern. Med. 2007. №146(ITC4). Р 1-13.

18. Marple B.F., Fornadley J.A., Patel A.A., Fineman S.M., Fromer L., Krouse J.H. et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction // Otolaryngol. Head Neck Surg. 2007. №136 (Suppl. 6). S107-S124.

19. Noon L. Prophylactic inoculation against hay fever // Lancet. 1911. №177. Р 1572-1573. doi: 10.1016/S0140-6736(00)78276-6.

20. Keith P.K., Desrosiers M., Laister T., Schellenberg R.R., Waserman S. The burden of allergic rhinitis in Canada: perspectives of physician and patients // Allergy Asthma Clin. Immunol. 2012. Jun. 1. №8(1). Р. 7.

21. Гущин И.С., Курбачева О.М. Аллергология и аллергенспецифическая иммунотерапия. М.: Фармарус Принт Медиа, 2010.

22. Cox L., Wallace D. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual // Immunol. Allergy Clin. North Am. 2011. №31. Р 561-599. doi: 10.1016/j.iac.2011.05.001.

23. Cauwenberg PVan, Bachert C., Passalacqua G. et al. Consensus statement on the treatment of allergic rhinitis // Allergy & Immunology. 2003. Vol. 2. №1. P 16-38.

24. Calderon M.A., Alves B., Jacobson M. et al. Allergen injection immunotherapy for seasonal allergic rhinitis // Cochrane Database Syst. Rev. 2007. №1. CD001936.

25. Abramson M.J., Puy R.M., Weiner J.M. Is allergen immunotherapy effective in asthma? A metaanalysis of randomized controlled trials // Am. J. Respir. Crit. Care Med. 1995. №151(4). Р. 969–974.

26. Bernstein D.I., Wanner M., Borish L., Liss G.M.Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001 // J. Allergy Clin. Immunol. 2004. №113. Р. 1129–1136.

27. Radulovic S., Wilson D., Calderon M., Durham S. Systematic reviews of sublingual immunotherapy (SLIT) // Allergy. 2011. №66. Р. 740–752.

28. Cox L.S., Larenas-Linnemann D., Nolte H., Weldon D., Finegold I., Nelson H.S. Sublingual immunotherapy: a comprehensive review // J. Allergy Clin. Immunol. 2006. №117. Р. 1021–1035.

29. Durham S.R., Emminger W., Kapp A. et al. Longterm clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQstandardized grass allergy immunotherapy tablet // J. Allergy Clin. Immunol. 2010. №125. Р. 131–138. e1-7-35.

30. Didier A., Worm M., Horak F., Sussman G., Malling H.J. et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis // J. Allergy Clin. Immunol. 2011. №128. Р. 559–566.

31. Novak N., Bieber T., Allam J.-P. Immunological mechanisms of sublingual allergen-specific immunotherapy // Allergy. 2011. №66. Р. 733–739.

32. Mascarell L., Lombardi V., Zimmer A., Louise A., Tourdot S., Van Overtvelt L. et al. Mapping of the lingual immune system reveals the presence of both regulatory and effect CD4+ T cells // Clin. Exp. Allergy. 2009. №39. Р. 1910–1919.

33. Allam J.P., Stojanovski G., Friedrichs N., Peng W., Bieber T., Wenzel J. et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? // Allergy. 2008. №63. Р. 720–727.

34. Canonica G.W., Bousquet J., Casale T., Lockey R.F., Baena-Cagnani C.E., Pawankar R. et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper, 2009 // Allergy. 2009. №64 (Suppl. 91). Р. 1–59.

35. Calderon M., Moesges R., Hellmich M., Demoly P. Towards evidence-based medicine in specific grass pollen immunotherapy // Allergy. 2010. №65. Р. 420–434.

36. Lopez D.G.L. Systemic Reactions Secondary to Allergen-Specific Immunotherapy in a Population of Monterrey, Mexico // J. Allergy Clin. Immunol. 2003. №111. S72.

37. Roy S.R., Sigmon J.R., Olivier J., Moffitt J.E., Brown D.A., Marshall G.D. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy // Ann. Allergy Asthma Immunol. 2007. №99. Р. 82–86.

38. Ruëff F., Przybilla B., Biló M.B., Müller U., Scheipl F., Aberer W., Birnbaum J., Bodzenta-Lukaszyk A., Bonifazi F., Bucher C., Campi P., Darsow U., Egger C., Haeberli G., Hawranek T., Körner M., Kucharewicz I., Küchenhoff H., Lang R., Quercia O., Reider N., Severino M., Sticherling M., Sturm G.J., Wüthrich B. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity // J. Allergy Clin. Immunol. 2009. №124. Р. 1047–1054.


Review

For citations:


O.s. drobik , A.yu. nasunova . House dust mites: invisible signs of visible problems. Modern approaches to the treatment of dust mite allergies. Meditsinskiy sovet = Medical Council. 2013;(7):59-65. (In Russ.) https://doi.org/10.21518/2079-701X-2013-7-59-65

Views: 479


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)